N A Williams
Overview
Explore the profile of N A Williams including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
91
Citations
1223
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
3.
Bailey J, Vince V, Williams N, Cogan T
Benef Microbes
. 2017 Jun;
8(4):605-614.
PMID: 28618865
Treatment of inflammatory bowel disease (IBD) is mainly based on suppression of symptoms, often with numerous side effects. Trials of probiotics in IBD have frequently produced disappointing results. The majority...
4.
Donaldson D, Apostolaki M, Bone H, Richards C, Williams N
Mucosal Immunol
. 2012 Oct;
6(3):535-46.
PMID: 23032791
The B subunit of E. coli heat-labile enterotoxin (EtxB) protects against the development of T helper type 1 (Th1)-mediated autoimmune pathologies in mice. Protection was transferable with splenic CD4(+) T...
5.
Williams N, Fournier J, Coday M, Richey P, Tylavsky F, Hare M
Child Care Health Dev
. 2012 Aug;
39(6):825-34.
PMID: 22882115
Objective: To determine whether there is an association between body mass index (BMI) and body esteem in young overweight and obese urban children, and to test peer relationship difficulties and...
6.
Clarke E, Williams N, Dull P, Findlow J, Borrow R, Finn A, et al.
Mucosal Immunol
. 2012 Jul;
6(2):288-96.
PMID: 22806100
Colonization of the nasopharyngeal mucosa by meningococcus and other polysaccharide (PS)-encapsulated bacteria precedes invasion. PS-conjugate vaccines induce PS-specific B-cell memory (B(MEM)) and also prevent colonization, thus blocking person-to-person transmission, generating...
7.
Donaldson D, Tong K, Williams N
Mucosal Immunol
. 2010 Oct;
4(2):227-38.
PMID: 20944556
Understanding the processes by which certain mucosal pathogens and their products induce regulatory T cells (Tregs) is important in determining mechanisms of pathogenicity and may point toward their use in...
8.
Horton R, Vidarsson G, Virji M, Williams N, Heyderman R
Microb Pathog
. 2009 Jun;
46(5):253-60.
PMID: 19486642
Despite high carriage rates of Neisseria meningitidis, incidence of meningococcal disease remains low, partially due to development of natural immunity. We have previously demonstrated an inverse relationship between salivary anti-meningococcal...
9.
Horton R, Stuart J, Christensen H, Borrow R, Guthrie T, Davenport V, et al.
Epidemiol Infect
. 2005 Sep;
133(5):883-9.
PMID: 16181509
Asymptomatic carriage of Neisseria meningitidis is common (5-35% of individuals) while the incidence of invasive meningococcal disease is fairly low (<1-5 per 100,000 per annum in Europe). Naturally acquired protective...
10.
Smartt H, Elder D, Hicks D, Williams N, Paraskeva C
Br J Cancer
. 2003 Oct;
89(7):1358-65.
PMID: 14520472
Nonsteroidal anti-inflammatory drugs (NSAIDs) inhibit colorectal neoplasia, an effect that is associated with their ability to induce apoptosis. Although NSAIDs have been reported to inhibit NF-kappaB, more recent studies show...